SureTrader Advertisement PRTC
Home > Boards > US OTC > Biotechs > PharmaCyte Biotech Inc. (PMCB)

NVLX

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
NYC Trader Member Profile
 
Followed By 1,138
Posts 143,448
Boards Moderated 6
Alias Born 01/25/09
160x600 placeholder
PharmaCyte Biotech to Present Clinical Trial at Marcum MicroCap, ASCO and BIO International Conferences "GlobeNewswire Inc." - 5/26/2016 9:20:00 AM
PharmaCyte Biotech to Engage Principal Investigator for Clinical Trial in Pancreatic Cancer "GlobeNewswire Inc." - 5/24/2016 9:00:00 AM
PharmaCyte Biotech Receives ‘Notice of Allowance’ for Patent Protection of the Melligen Cells to Treat Diabetes "GlobeNewswire Inc." - 5/12/2016 9:34:25 AM
PharmaCyte Biotech Clears Major Milestone on Path to FDA Clinical Trial "Marketwired" - 5/5/2016 7:15:00 AM
PharmaCyte Biotech Appoints Former Johnson & Johnson Executive as Senior Business Development Advisor "GlobeNewswire Inc." - 5/3/2016 9:25:00 AM
PharmaCyte Biotech’s Live-Cell Encapsulation Facility is Commissioned for GMP Manufacture "GlobeNewswire Inc." - 4/25/2016 9:20:00 AM
Broad Street Issues New Watch List Report "InvestorsHub NewsWire" - 4/19/2016 8:00:00 AM
PharmaCyte Biotech’s Encapsulation Facility for Pancreatic Cancer Therapy Deemed Suitable by Thai FDA "GlobeNewswire Inc." - 4/8/2016 9:20:00 AM
PharmaCyte Biotech Finalizes Design of Pancreatic Cancer Clinical Trial and Identifies Trial Sites under Consideration "GlobeNewswire Inc." - 3/31/2016 9:20:00 AM
PharmaCyte Biotech Discusses Protection Strategy for Cancer and Diabetes Therapies "GlobeNewswire Inc." - 3/15/2016 9:25:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 3/8/2016 5:37:03 PM
PharmaCyte Biotech Reports on Audit of Live-Cell Encapsulation Facility by Chamow & Associates "GlobeNewswire Inc." - 3/3/2016 9:25:00 AM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 3/2/2016 5:44:04 PM
PharmaCyte Biotech Addresses Development of Targeted Cannabinoid Chemotherapy "GlobeNewswire Inc." - 3/1/2016 9:25:00 AM
PharmaCyte Biotech Pancreatic Cancer Treatment to Target Recently Identified Forms of Pancreatic Cancer "GlobeNewswire Inc." - 2/26/2016 9:25:00 AM
PharmaCyte Biotech on Schedule for 2016 Cancer Clinical Trial in Pancreatic Cancer "GlobeNewswire Inc." - 2/24/2016 9:00:00 AM
PharmaCyte Biotech Issues Update on Preparations for Its Pancreatic Cancer Clinical Trial "GlobeNewswire Inc." - 2/22/2016 9:25:00 AM
Small Caps and ETF's with Near Term Catalyst; Independent Research "InvestorsHub NewsWire" - 2/16/2016 8:50:00 AM
Stonegate Capital Partners Publishes Research Report on PharmaCyte Biotech "GlobeNewswire Inc." - 2/10/2016 9:32:58 AM
Johnson & Johnson and Big Pharma Could Find a Diabetes "Cure" With PharmaCyte Biotech's Type 1 Diabetes Treatment "Marketwired" - 2/8/2016 9:00:00 AM
PharmaCyte Executives Meet With Translational Drug Development to Advance Pancreatic Cancer Clinical Trial "GlobeNewswire Inc." - 1/25/2016 9:25:00 AM
PharmaCyte Biotech Introduces Cell-in-a-Box as a Novel Treatment for Pancreatic Cancer and Potential Cure for Type 1 Diabetes... "GlobeNewswire Inc." - 1/19/2016 9:25:00 AM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 1/19/2016 6:17:47 AM
Amended Quarterly Report (10-q/a) "Edgar (US Regulatory)" - 1/19/2016 6:16:25 AM
Amended Quarterly Report (10-q/a) "Edgar (US Regulatory)" - 1/19/2016 6:13:24 AM
NYC Trader   Friday, 05/10/13 07:49:08 AM
Re: None
Post # of 49064 
NVLX
Link: http://www.otcmarkets.com/stock/NVLX/company-info
Ticker: $NVLX
OTC Market Tier: OTCQB
CIK code: 0001157075
Company name: Nuvilex, Inc.
Company website: http://www.nuvilex.com
Incorporated In: NV, USA


Visit my board"NY Penny Stock Exchange" for today's pick at http://investorshub.advfn.com/boards/board.aspx?board_id=16752
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist